Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cell Immunity to Influenza Vaccine in RA
NCT01002716Phase 4Unknown
- Sponsor
- Tel Aviv Sourasky Medical Center
- Start
- Oct 2009
- Primary completion
- Mar 2010
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of influenza vaccine, inactivated, surface antigen in influenza, sponsored by Tel Aviv Sourasky Medical Center. Status: unknown.
02
Drugs
influenza vaccine, inactivated, surface antigen
03
Conditions
influenza
Beyond the preview
Go deeper on NCT01002716.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01002716.